Valion Bio (VBIO) EPS (Basic) Growth (3y) (2024 - 2026)
Valion Bio (VBIO) EPS (Basic) Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | -38.31% |
| 10 | Valion Bio | 408,979.63 | -1.79 Mn | -45,000.00 | 42.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -297.86% |
| Dec 31, 2025 | 31.33% |
| Sep 30, 2025 | -90.34% |
| Jun 30, 2025 | -90.21% |
| Mar 31, 2025 | -122.08% |
| Dec 31, 2024 | -100.07% |
| Sep 30, 2024 | 21.44% |
| Jun 30, 2024 | 14.99% |
| Mar 31, 2024 | -21.58% |